GANX - Gain Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GANX is currently covered by 3 analysts with an average price target of $6.53. This is a potential upside of $4.8 (277.46%) from yesterday's end of day stock price of $1.73.

Gain Therapeutics's activity chart (see below) currently has 14 price targets and 29 ratings on display. The stock rating distribution of GANX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 5% with an average time for these price targets to be met of 42.8 days.

Highest price target for GANX is $8, Lowest price target is $6, average price target is $7.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 03-Jul-2025. First documented stock forecast 12-Apr-2021.

Best performing analysts who are covering GANX - Gain Therapeutics:

Mayank Mamtani Keay Nakae Raghuram Selvaraju Thomas Shrader Hartaj Singh

Currently out of the existing stock ratings of GANX, 18 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

$6.24 (354.55%)

$8

2 months 8 days ago
(03-Jul-2025)

0/16 (0%)

$6.31 (373.37%)

Buy

$6

$4.24 (240.91%)

$6

5 months 14 days ago
(28-Mar-2025)

0/5 (0%)

$3.93 (189.86%)

Buy

$9

1 years 28 days ago
(14-Aug-2024)

0/4 (0%)

$5.61 (165.49%)

Buy

$10

$7.27 (266.30%)

$30

2 years 10 months ago
(11-Nov-2022)

0/2 (0%)

$6.79 (211.53%)

Buy

$5

$2.27 (83.15%)

$11

3 years 23 days ago
(19-Aug-2022)

1/4 (25%)

$1.34 (36.61%)

214

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GANX (Gain Therapeutics) average time for price targets to be met?

On average it took 42.8 days on average for the stock forecasts to be realized with a an average price target met ratio 5

Which analyst has the current highest performing score on GANX (Gain Therapeutics) with a proven track record?

MAYANK MAMTANI

Which analyst has the current lower performing score on GANX (Gain Therapeutics) with a proven track record?

HARTAJ SINGH

Which analyst has the most public recommendations on GANX (Gain Therapeutics)?

Mayank Mamtani works at B. RILEY and has 2 price targets and 1 ratings on GANX

Which analyst is the currently most bullish on GANX (Gain Therapeutics)?

Thomas Shrader with highest potential upside - $7.27

Which analyst is the currently most reserved on GANX (Gain Therapeutics)?

Hartaj Singh with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?